CD19 and psoriasis: To evaluate which type of cells was important in CAV-1 downregulation, immunofluorescent staining of PBMCs was performed and CAV-1 intensities quantified by fluorescent microscopy were compared between patients with psoriasis and controls in CD3+ T cells, CD19+ B cells, and CD14+ monocytes.